{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:23:38Z","timestamp":1791213818504,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.ijrobp.2009.04.054","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T08:16:35Z","timestamp":1250756195000},"page":"98-105","source":"Crossref","is-referenced-by-count":81,"title":["Phase I\/II Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme"],"prefix":"10.1016","volume":"77","author":[{"given":"Masashi","family":"Mizumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Hashii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayae","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetsugu","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tokuuye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.04.054_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","article-title":"An analysis of dose-effect relationship in the radiotherapy of malignant gliomas","volume":"5","author":"Walker","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib3","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S","article-title":"Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults","volume":"71","author":"Fine","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"Stewart","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials","volume":"85","author":"Curran","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0360-3016(97)00485-9","article-title":"Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06","volume":"40","author":"Scott","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1215\/S1152851703000620","article-title":"Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis","volume":"6","author":"Lamborn","year":"2004","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1215\/15228517-2007-038","article-title":"Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma","volume":"10","author":"Filippini","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib9","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2005.00.331","article-title":"Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme","volume":"23","author":"Athanassiou","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1200\/JCO.20.5.1375","article-title":"Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide","volume":"20","author":"Stupp","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ijrobp.2007.02.043","article-title":"Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme","volume":"68","author":"Moyal","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ijrobp.2006.01.018","article-title":"Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of North Central Cancer Treatment Group protocol N0177","volume":"65","author":"Krishnan","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S1470-2045(05)70395-8","article-title":"High-dose conformal radiotherapy for supratentorial malignant glioma: A historical comparison","volume":"6","author":"Tanaka","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3171\/jns.1999.91.2.0251","article-title":"Accelerated fractionated proton\/photon irradiation to 90 cobalt Gray equivalent for glioblastoma multiforme: Results of a phase II prospective trial","volume":"91","author":"Fitzek","year":"1999","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijrobp.2007.03.003","article-title":"Phase I\/II clinical trial of carbon ion radiotherapy for malignant gliomas: Combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy","volume":"69","author":"Mizoe","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.ijrobp.2006.02.042","article-title":"A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023","volume":"65","author":"Cardinale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol","volume":"60","author":"Souhami","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(98)00092-9","article-title":"Relative biological effectiveness of proton beams in clinical therapy","volume":"50","author":"Gerweck","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib20","unstructured":"National Cancer Institute. National Cancer Institute common toxicity criteria. http:\/\/ctep.cancer.gov\/reporting\/ctc.html."},{"key":"10.1016\/j.ijrobp.2009.04.054_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(03)00819-8","article-title":"The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial","volume":"58","author":"Sultanem","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0360-3016(03)01623-7","article-title":"Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme","volume":"58","author":"Floyd","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-2-26","article-title":"Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme","volume":"2","author":"Fuller","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/030089160709300304","article-title":"Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide","volume":"93","author":"Donato","year":"2007","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0360-3016(95)02038-1","article-title":"Hypofractionated radiation therapy in patients with glioblastoma multiforme: Results of treatment and impact of prognostic factors","volume":"34","author":"Slotman","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(07)70384-4","article-title":"Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981-22981\/CE.3","volume":"9","author":"Gorlia","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib27","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","article-title":"Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial","volume":"24","author":"Mirimanoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijrobp.2008.05.034","article-title":"Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation therapy oncology group trial 98-03","volume":"73","author":"Tsien","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","article-title":"Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05","volume":"47","author":"Shaw","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0360-3016(99)00336-3","article-title":"Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas","volume":"45","author":"Cho","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/cncr.23562","article-title":"Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide","volume":"113","author":"Taal","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.04.054_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3171\/jns.1986.64.1.0053","article-title":"Effects of ACNU and radiotherapy on malignant glioma","volume":"64","author":"Takakura","year":"1986","journal-title":"J Neurosurg"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609006531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609006531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T03:02:30Z","timestamp":1558494150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609006531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0360301609006531"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.054","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}